Autoimmune lymphoproliferative syndrome
Clinical trials for Autoimmune lymphoproliferative syndrome explained in plain language.
Never miss a new study
Get alerted when new Autoimmune lymphoproliferative syndrome trials appear
Sign up with your email to follow new studies for Autoimmune lymphoproliferative syndrome, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill could shrink spleen and lymph nodes in rare ALPS disease
Disease control Recruiting nowThis study tests a drug called soquelitinib in 15 people aged 16 and older with autoimmune lymphoproliferative syndrome (ALPS). The goal is to see if the drug can shrink an enlarged spleen or lymph nodes and improve low blood cell counts. Participants take the pill twice daily fo…
Matched conditions: AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Scientists track rare immune disease to unlock its secrets
Knowledge-focused Recruiting nowThis study follows people with autoimmune lymphoproliferative syndrome (ALPS) and their relatives over many years. Researchers will collect blood and tissue samples, track symptoms, and study genetics to better understand why the immune system attacks the body. The goal is to lea…
Matched conditions: AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC